Annual ROE
-77.32%
-103.54%-394.89%
December 1, 2023
Summary
- As of February 8, 2025, SXTP annual return on equity is -77.32%, with the most recent change of -103.54% (-394.89%) on December 1, 2023.
- During the last 3 years, SXTP annual ROE has fallen by -94.65% (-546.16%).
- SXTP annual ROE is now -394.89% below its all-time high of 26.22%, reached on December 31, 2022.
Performance
SXTP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-144.62%
-115.60%-398.35%
September 1, 2024
Summary
- As of February 8, 2025, SXTP quarterly return on equity is -144.62%, with the most recent change of -115.60% (-398.35%) on September 1, 2024.
- Over the past year, SXTP quarterly ROE has dropped by -224.63% (-280.75%).
- SXTP quarterly ROE is now -280.75% below its all-time high of 80.01%, reached on March 1, 2024.
Performance
SXTP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SXTP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -394.9% | -280.8% |
| 3 y3 years | -546.2% | -280.8% |
| 5 y5 years | -546.2% | -280.8% |
SXTP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -394.9% | at low | -280.8% | at low |
| 5 y | 5-year | -394.9% | at low | -280.8% | at low |
| alltime | all time | -394.9% | at low | -280.8% | at low |
60 Degrees Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -144.62%(+398.3%) |
| Jun 2024 | - | -29.02%(-136.3%) |
| Mar 2024 | - | 80.01%(+58.5%) |
| Dec 2023 | -77.32% | 50.48%(+114.5%) |
| Sep 2023 | - | 23.53%(-43.8%) |
| Jun 2023 | - | 41.89%(+13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | 36.77%(+34.6%) |
| Dec 2022 | 26.22%(+8.4%) | 27.32%(-8.6%) |
| Sep 2022 | - | 29.90%(+18.9%) |
| Jun 2022 | - | 25.15%(+94.5%) |
| Mar 2022 | - | 12.93%(+67.1%) |
| Dec 2021 | 24.19%(+39.6%) | 7.74% |
| Dec 2020 | 17.33% | - |
FAQ
- What is 60 Degrees Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals annual ROE year-on-year change?
- What is 60 Degrees Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals quarterly ROE year-on-year change?
What is 60 Degrees Pharmaceuticals annual return on equity?
The current annual ROE of SXTP is -77.32%
What is the all time high annual ROE for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high annual return on equity is 26.22%
What is 60 Degrees Pharmaceuticals annual ROE year-on-year change?
Over the past year, SXTP annual return on equity has changed by -103.54% (-394.89%)
What is 60 Degrees Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SXTP is -144.62%
What is the all time high quarterly ROE for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high quarterly return on equity is 80.01%
What is 60 Degrees Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SXTP quarterly return on equity has changed by -224.63% (-280.75%)